Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

The Role of Day 14 Bone Marrow Analysis in Determining Leukemia Free Survival and Overall Survival

Thomas Ollila, MD, John L Reagan, MD, Jorge J Castillo, MD, James N Butera, MD, Eric S Winer, MD, Michael S Cardin, RPh

Blood (2015) 126 (23): 4974.

https://doi.org/10.1182/blood.V126.23.4974.4974

Published: 2015

Journal Articles

Recovery Blasts in the Peripheral Blood in AML Patients Who Obtain a Complete Remission Is a Favorable Prognostic Indicator

Nathaniel M. Cook, MD, James N. Butera, MD, John L Reagan, MD

Blood (2014) 124 (21): 5335.

https://doi.org/10.1182/blood.V124.21.5335.5335

Published: 2014

Journal Articles

Grey Zone Lymphoma, Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma: Better Results With CHOP-Like Regimens

Omar Nadeem, MD, Diana O Treaba, MD, Jorge J Castillo, MD, James N Butera, MD

Blood (2013) 122 (21): 5105.

https://doi.org/10.1182/blood.V122.21.5105.5105

Published: 2013

Journal Articles

Combination Of Ofatumumab and Bortezomib In Patients With Indolent B-Cell Lymphomas Who Relapsed >6 Months After Rituximab-Containing Regimen: A Brown University Oncology Research Group Phase II Study

Jorge J Castillo, MD, James N Butera, MD, Eric S Winer, MD, Frederick Lansigan, MD, Kayla Rosati, Howard Safran, MD

Blood (2013) 122 (21): 5121.

https://doi.org/10.1182/blood.V122.21.5121.5121

Published: 2013

Journal Articles

Spontaneous Remission of Chronic Lymphocytic Leukemia, Possibly More Rare Then Previously Reported?

Peter Nakhla, MD, James N Butera, MD, Jorge J Castillo, MD, Diana O Treaba, MD, Peter J Quesenberry, MD

Blood (2012) 120 (21): 4589.

https://doi.org/10.1182/blood.V120.21.4589.4589

Published: 2012

Journal Articles

Incidence of Direct Thrombin Inhibitor Therapy for Presumed Heparin Induced Thrombocytopenia Before and After Implementation of Heparin Induced Thrombocytopenia IgG Subtype Antibody Test

Randall R Ingham, II, MD, John L. Reagan, MD, Samir Dalia, MD, Joseph D. Sweeney, MD, James N. Butera, MD

Blood (2012) 120 (21): 3336.

https://doi.org/10.1182/blood.V120.21.3336.3336

Published: 2012

Journal Articles

Clinicopathological Differences Between Asian and Western Patients with De Novo Diffuse Large B Cell Lymphoma Treated with R-CHOP

Natalie Sinclair, MD, Brady E Beltran, MD, Moo-Kon Song, MD, Ivana Ilic, MD, Sirpa Leppa, Heidy Nyman, MD, Silvia Uccella, MD, Ritsuko Seki, PhD, Jun-ming Li, MD, Diana O Treaba, MD, James N Butera, MD, Jorge J Castillo, MD

Blood (2011) 118 (21): 2665.

https://doi.org/10.1182/blood.V118.21.2665.2665

Published: 2011

Journal Articles

Black Cohosh Induced Pancytopenia: Case Report

Zeina G El Amil, MD, James N Butera, MD

Blood (2011) 118 (21): 4383.

https://doi.org/10.1182/blood.V118.21.4383.4383

Published: 2011

Journal Articles

The Immunohistochemical Profile and Other Prognostic Factors In Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Jorge J Castillo, MD, Brady Beltran, MD, Joo-Seop Chung, MD, Ivana Ilic, MD, Sirpa Leppa, Ritsuko Seki, PhD, Silvia Uccella, MD, Zu-Guang Xia, MD, James N Butera, MD

Blood (2010) 116 (21): 4126.

https://doi.org/10.1182/blood.V116.21.4126.4126

Published: 2010

Journal Articles

Successful Treatment of Acquired Amegakaryocytic Thrombocytopenia with Rituximab: A Case Report.

Laura R. Goldberg, MD, PhD, Lewis Glasser, MD, Tony Wu, MD, Ikue Shimizu, MD, Peter J. Quesenberry, MD, James N. Butera, MD

Blood (2009) 114 (22): 4223.

https://doi.org/10.1182/blood.V114.22.4223.4223

Published: 2009

Journal Articles

Phase I Trial Examining Addition of Gemcitabine to CHOP in Intermediate Grade NHL.

John L. Reagan, MD, James N. Butera, MD, Alan G. Rosmarin, MD, Ahmed Nadeem, MD, Fred J. Schiffman, MD, William Sikov, MD, Eric Winer, MD, Anthony Mega, MD

Blood (2009) 114 (22): 4765.

https://doi.org/10.1182/blood.V114.22.4765.4765

Published: 2009

Journal Articles

Heparin Induced Thrombocytopenia; A Diagnostic Dilemma.

John L. Reagan, MD, Samir Dalia, MD, James N. Butera, MD

Blood (2009) 114 (22): 4468.

https://doi.org/10.1182/blood.V114.22.4468.4468

Published: 2009

NARROW

The Role of Day 14 Bone Marrow Analysis in Determining Leukemia Free Survival and Overall Survival

Recovery Blasts in the Peripheral Blood in AML Patients Who Obtain a Complete Remission Is a Favorable Prognostic Indicator

Grey Zone Lymphoma, Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma: Better Results With CHOP-Like Regimens

Combination Of Ofatumumab and Bortezomib In Patients With Indolent B-Cell Lymphomas Who Relapsed >6 Months After Rituximab-Containing Regimen: A Brown University Oncology Research Group Phase II Study

Spontaneous Remission of Chronic Lymphocytic Leukemia, Possibly More Rare Then Previously Reported?

Incidence of Direct Thrombin Inhibitor Therapy for Presumed Heparin Induced Thrombocytopenia Before and After Implementation of Heparin Induced Thrombocytopenia IgG Subtype Antibody Test

Clinicopathological Differences Between Asian and Western Patients with De Novo Diffuse Large B Cell Lymphoma Treated with R-CHOP

Black Cohosh Induced Pancytopenia: Case Report

The Immunohistochemical Profile and Other Prognostic Factors In Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Successful Treatment of Acquired Amegakaryocytic Thrombocytopenia with Rituximab: A Case Report.

Phase I Trial Examining Addition of Gemcitabine to CHOP in Intermediate Grade NHL.

Heparin Induced Thrombocytopenia; A Diagnostic Dilemma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only